Australia markets open in 9 hours 55 minutes

Standard BioTools Inc. (LAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.5950+0.0050 (+0.19%)
As of 10:05AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 967.60M
Enterprise value 597.22M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.72
Price/book (mrq)1.68
Enterprise value/revenue 4.71
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.64
52-week change 31.17%
S&P500 52-week change 327.84%
52-week high 33.1600
52-week low 31.5700
50-day moving average 32.5942
200-day moving average 32.4299

Share statistics

Avg vol (3-month) 32.56M
Avg vol (10-day) 32.79M
Shares outstanding 5373.59M
Implied shares outstanding 6373.59M
Float 849.4M
% held by insiders 11.11%
% held by institutions 172.88%
Shares short (30 Apr 2024) 411.42M
Short ratio (30 Apr 2024) 43.53
Short % of float (30 Apr 2024) 43.16%
Short % of shares outstanding (30 Apr 2024) 43.01%
Shares short (prior month 28 Mar 2024) 410.23M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin -70.98%
Operating margin (ttm)-29.42%

Management effectiveness

Return on assets (ttm)-9.39%
Return on equity (ttm)-22.74%

Income statement

Revenue (ttm)126.76M
Revenue per share (ttm)0.95
Quarterly revenue growth (yoy)-14.20%
Gross profit (ttm)N/A
EBITDA -79.12M
Net income avi to common (ttm)-135.98M
Diluted EPS (ttm)-1.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.45M
Total cash per share (mrq)0.37
Total debt (mrq)111.65M
Total debt/equity (mrq)118.03%
Current ratio (mrq)4.51
Book value per share (mrq)1.23

Cash flow statement

Operating cash flow (ttm)-97.28M
Levered free cash flow (ttm)-40.86M